Ledger.Open graph →
SEC Form D · filed August 13, 2015

4D Molecular Therapeutics Inc

Offering
$7.0M
Sold
$7.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
EMERYVILLE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

David Kirn · Emeryville, CAExec · DirectorDavid Schaffer · Emeryville, CADirectorTheresa Janke · Emeryville, CAExecChristopher L. O'Dell · New York, NYDirectorNoel C. Langlois · New York, NYExec · DirectorJeffrey H. Gelfand · New York, NYExecLee L. Spector · New York, NYDirectorGiselle H. Lopez-Velasco · New York, NYExec · DirectorFrancie L. Tai · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗